日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development and Application of Small Molecule-Peptide Conjugates as Cathepsin K-Specific Covalent Irreversible Inhibitors in Human Osteoclast and Lung Cancer.

小分子肽缀合物作为组织蛋白酶 K 特异性共价不可逆抑制剂在人类破骨细胞和肺癌中的开发与应用

Dey Gourab, Yakobovich Evalyn, Loboda Jure, Sinai-Turyansky Reut, Abramovitch-Dahan Chen, Merquiol Emmanuelle, Sridharan Nikhila, Itzhak Gal, Turk Boris, Wald Ori, Turk Dusan, Yona Simon, Levaot Noam, Blum Galia

The Role of GPR39 in Regulating Osteoblast Function, Bone Matrix Quality, and Gender-Specific Bone Homeostasis.

GPR39 在调节成骨细胞功能、骨基质质量和性别特异性骨稳态中的作用。

Chaterjee Biplab, Gozlan Gal, Abramovitch-Dahan Chen, Davydok Anton, Reiner-Benaim Anat, Krug Johannes, Jähn-Rickert Katharina, Busse Björn, Levaot Noam

Mapping the sclerostin-LRP4 binding interface identifies critical interaction hotspots in loops 1 and 3 of sclerostin.

通过绘制硬骨蛋白-LRP4结合界面,可以确定硬骨蛋白环1和环3中的关键相互作用热点

Katchkovsky Svetlana, Meiri Reut, Lacham-Hartman Shiran, Orenstein Yaron, Levaot Noam, Papo Niv

Comparative analysis of osteoclast function in symptomatic and asymptomatic individuals with cherubism-causing SH3BP2 mutation

对携带导致颌骨囊肿的SH3BP2突变的有症状和无症状个体进行破骨细胞功能比较分析

Abramovitch-Dahan, Chen; Katchkovsky, Svetlana; Zur, Yuval; Gozlan, Gal; Nimni, Nitsan; Droma, Eitan Bar; Givol, Navot; Geftler, Alex; Fraenkel, Merav; Reiner-Benaim, Anat; Søe, Kent; Levaot, Noam

Competitive blocking of LRP4-sclerostin binding interface strongly promotes bone anabolic functions

竞争性阻断LRP4-硬骨蛋白结合界面可显著促进骨骼合成代谢功能

Katchkovsky, Svetlana; Chatterjee, Biplab; Abramovitch-Dahan, Chen-Viki; Papo, Niv; Levaot, Noam

Schlafen2 mutation in mice causes an osteopetrotic phenotype due to a decrease in the number of osteoclast progenitors

小鼠的Schlafen2基因突变会导致破骨细胞祖细胞数量减少,从而引起骨硬化症表型。

Omar, Ibrahim; Guterman-Ram, Gali; Rahat, Dolev; Tabach, Yuval; Berger, Michael; Levaot, Noam